Interventions for Tuberculosis Control and Elimination 2002

183. Acocella G, Conti R, Luisetti M, Pozzi E, Grassi C. I. Absorption and metabolism
of the compounds used in the initial intensive phase of the short-course
regiments: single administration study. Am Rev Respir Dis 1985; 132: 510-5.
184. Maggi N, Furesz S, Pallanza R, Pelizza G. Rifampicin desacetylation in the
human organism. Arzneim -Forsch /Drug Res 1969; 19: 651-4.
185. Scotti R. Sex difference in blood levels of some antibiotics. Chemotherapy
1973; 18: 205-11.
186. Siegler DI, Burley DM, Bryant M, Citron KM, Standen SM. Effect of meals
on rifampicin absorption. Lancet 1971; 2: 197-8.
187. Peloquin CA, Namdar R, Singleton MD, Nix DE. Pharmacokinetics of rifampin
under fasting conditions, with food, and with antacids. Chest 1999; 115: 12-8.
188. Purohit SD, Sarkar SK, Gupta ML, Jain DK, Gupta PR, Mehta YR. Dietary constituents
and rifampicin absorption. (Correspondence). Tubercle 1987; 68: 151-2.
189. Chan K. Rifampicin concentrations in cerebrospinal fluid and plasma of the rabbit
by high performance liquid chromatography.
1986; 8: 721-6.
Meth Find Exptl Clin Pharmacol
190. Cavenaghi R. Rifampicin raw material characteristics and their effect on bioavailability.
Bull Int Union Tuberc Lung Dis 1989; 64: 36-41.
191. Blomberg B, Spinaci S, Fourie B, Laing R. The rationale for recommending
fixed-dose combination tablets for treatment of tuberculosis.
Organ 2001; 79: 61-8.
Bull World Health
192. Pelizza G, Nebuloni M, Ferrari P, Gallo GG.
Farmaco Ed Sci 1977; 32: 471-81.
Polymorphism of rifampicin.
193. Henwood SQ, de Villiers MM, Liebenberg W, Lötter AP. Solubility and dissolution
properties of generic rifampicin raw materials.
2000; 26: 403-8.
Drug Dev Industr Pharm
194. Girling DJ, Hitze KL.
1979; 57: 45-9.
Adverse reactions to rifampicin. Bull World Health Organ
195. Curci G, Bergamini N, Delli Veneri F, Ninni A, Ninni V. Sul comportamento
della cinetica della rifampicina e del tasso bilirubinemico dopo somministrazione
isolata of ripetuta di differenti dosi per kg di peso corporeo nell’uomo.
Monaldi 1970; 25: 427-40.
Arch
196. McColl KEL, Thompson GG, El Omar E, Moore MR, Park BK, Brodie MJ.
Effect of rifampicin on haem and bilirubin metabolism in man.
1987; 23: 553-9.
Br J Pharmacol
197. Sarma GR, Immanuel C, Kailasam S, Narayana ASL, Venkatesan P. Rifampininduced
release of hydrazine from isoniazid. A possible cause of hepatitis during
treatment of tuberculosis with regimens containing isoniazid and rifampin.
Am Rev Respir Dis 1986; 133: 1072-5.
198. Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin.
A meta-analysis. Chest 1991; 99: 465-71.
182